Hospitalisation among vaccine breakthrough COVID-19 infections.

Juthani, Prerak V; Gupta, Akash; Borges, Kelly A; Price, Christina C; Lee, Alfred I; Won, Christine H; Chun, Hyung J

Juthani, Prerak V; Gupta, Akash; Borges, Kelly A; Price, Christina C; Lee, Alfred I; Won, Christine H; Chun, Hyung J.

Juthani PV; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06511, USA.
Gupta A; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06511, USA.
Borges KA; Yale Center for Clinical Investigation, Yale School of Medicine, New Haven, CT 06511, USA.
Price CC; Section of Immunology, Yale School of Medicine, New Haven, CT 06511, USA.
Lee AI; Section of Haematology, Yale School of Medicine, New Haven, CT 06511, USA.
Won CH; Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT 06511, USA.
Chun HJ; Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06511, USA. Electronic address: hyung.chun@yale.edu.

Lancet Infect Dis ; 21(11): 1485-1486, 2021 11.

Article in English | MEDLINE | ID: covidwho-1561094

Subject(s)

COVID-19; Vaccines; COVID-19 Vaccines; Hospitalization; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S1473-3099(21)00558-2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google